Valneva SE inked a $32 million contract with the U.S. Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO. The DoD will buy a minimum of $32 million worth of IXIARO vaccines with the possibility to purchase additional doses during the coming twelve months. Deliveries of the vaccine will commence immediately. According to the company, IXIARO is the only JE vaccine approved by the U.S. FDA, having been developed through a cooperative research and deve...